Cargando…
The Prognostic Utility of Lymphocyte-Based Measures and Ratios in Chemotherapy-Induced Febrile Neutropenia Patients following Granulocyte Colony-Stimulating Factor Therapy
Background and Objectives: Chemotherapy-induced febrile neutropenia is the most widespread oncologic emergency with high morbidity and mortality rates. Herein we present a retrospective risk factor identification study to evaluate the prognostic role of lymphocyte-based measures and ratios in a coho...
Autores principales: | , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9695543/ https://www.ncbi.nlm.nih.gov/pubmed/36363465 http://dx.doi.org/10.3390/medicina58111508 |
_version_ | 1784838087265746944 |
---|---|
author | Halalsheh, Omar M. Al Zu’bi, Yazan O. Al Sharie, Ahmed H. Wafai, Farouk H. Alabdallah, Nadeem AlSeidi, Jumana Hussein, Alia A. Daoud, Majd N. Malkawi, Abubaker A. Alomari, Ahmad O. Alshari, Osama |
author_facet | Halalsheh, Omar M. Al Zu’bi, Yazan O. Al Sharie, Ahmed H. Wafai, Farouk H. Alabdallah, Nadeem AlSeidi, Jumana Hussein, Alia A. Daoud, Majd N. Malkawi, Abubaker A. Alomari, Ahmad O. Alshari, Osama |
author_sort | Halalsheh, Omar M. |
collection | PubMed |
description | Background and Objectives: Chemotherapy-induced febrile neutropenia is the most widespread oncologic emergency with high morbidity and mortality rates. Herein we present a retrospective risk factor identification study to evaluate the prognostic role of lymphocyte-based measures and ratios in a cohort of chemotherapy-induced febrile neutropenia patients following granulocyte colony-stimulating factor (G-CSF) therapy. Materials and Methods: The electronic medical records at our center were utilized to identify patients with a first attack of chemotherapy-induced febrile neutropenia and were treated accordingly with G-CSF between January 2010 to December 2020. Patients’ demographics and disease characteristics along with laboratory tests data were extracted. Prognosis-related indicators were the absolute neutrophil count (ANC) at admission and the following 6 days besides the length of stay and mortality rate. Results: A total of 80 patients were enrolled, which were divided according to the absolute lymphocyte count at admission into two groups, the first includes lymphopenia patients (n = 55) and the other is the non-lymphopenia group (n = 25) with a cutoff point of 700 lymphocytes/μL. Demographics and baseline characteristics were generally insignificant among the two groups but the white blood cell count was higher in the non-lymphopenia group. ANC, neutrophils percentage and ANC difference in reference to admission among the two study groups were totally insignificant. The same insignificant pattern was observed in the length of stay and the mortality rate. Univariate analysis utilizing the ANC difference compared to the admission day as the dependent variable, revealed no predictability role in the first three days of follow up for any of the variables included. However, during the fourth day of follow up, both WBC (OR = 0.261; 95% CI: 0.075, 0.908; p = 0.035) and lymphocyte percentage (OR = 1.074; 95% CI: 1.012, 1.141; p = 0.019) were marginally significant, in which increasing WBC was associated with a reduction in the likelihood of ANC count increase, compared to the lymphocyte percentage which exhibited an increase in the likelihood. In comparison, sequential ANC difference models demonstrated lymphocyte percentage (OR = 0.961; 95% CI: 0.932, 0.991; p = 0.011) and monocyte-to-lymphocyte ratio (OR = 7.436; 95% CI: 1.024, 54.020; p = 0.047) reduction and increment in the enhancement of ANC levels, respectively. The fifth day had WBC (OR = 0.790; 95% CI: 0.675, 0.925; p = 0.003) to be significantly decreasing the likelihood of ANC increment. Conclusions: we were unable to determine any concrete prognostic role of lymphocyte-related measures and ratios. It is plausible that several limitations could have influenced the results obtained, but as far as our analysis is concerned ALC role as a predictive factor for ANC changes remains questionable. |
format | Online Article Text |
id | pubmed-9695543 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-96955432022-11-26 The Prognostic Utility of Lymphocyte-Based Measures and Ratios in Chemotherapy-Induced Febrile Neutropenia Patients following Granulocyte Colony-Stimulating Factor Therapy Halalsheh, Omar M. Al Zu’bi, Yazan O. Al Sharie, Ahmed H. Wafai, Farouk H. Alabdallah, Nadeem AlSeidi, Jumana Hussein, Alia A. Daoud, Majd N. Malkawi, Abubaker A. Alomari, Ahmad O. Alshari, Osama Medicina (Kaunas) Article Background and Objectives: Chemotherapy-induced febrile neutropenia is the most widespread oncologic emergency with high morbidity and mortality rates. Herein we present a retrospective risk factor identification study to evaluate the prognostic role of lymphocyte-based measures and ratios in a cohort of chemotherapy-induced febrile neutropenia patients following granulocyte colony-stimulating factor (G-CSF) therapy. Materials and Methods: The electronic medical records at our center were utilized to identify patients with a first attack of chemotherapy-induced febrile neutropenia and were treated accordingly with G-CSF between January 2010 to December 2020. Patients’ demographics and disease characteristics along with laboratory tests data were extracted. Prognosis-related indicators were the absolute neutrophil count (ANC) at admission and the following 6 days besides the length of stay and mortality rate. Results: A total of 80 patients were enrolled, which were divided according to the absolute lymphocyte count at admission into two groups, the first includes lymphopenia patients (n = 55) and the other is the non-lymphopenia group (n = 25) with a cutoff point of 700 lymphocytes/μL. Demographics and baseline characteristics were generally insignificant among the two groups but the white blood cell count was higher in the non-lymphopenia group. ANC, neutrophils percentage and ANC difference in reference to admission among the two study groups were totally insignificant. The same insignificant pattern was observed in the length of stay and the mortality rate. Univariate analysis utilizing the ANC difference compared to the admission day as the dependent variable, revealed no predictability role in the first three days of follow up for any of the variables included. However, during the fourth day of follow up, both WBC (OR = 0.261; 95% CI: 0.075, 0.908; p = 0.035) and lymphocyte percentage (OR = 1.074; 95% CI: 1.012, 1.141; p = 0.019) were marginally significant, in which increasing WBC was associated with a reduction in the likelihood of ANC count increase, compared to the lymphocyte percentage which exhibited an increase in the likelihood. In comparison, sequential ANC difference models demonstrated lymphocyte percentage (OR = 0.961; 95% CI: 0.932, 0.991; p = 0.011) and monocyte-to-lymphocyte ratio (OR = 7.436; 95% CI: 1.024, 54.020; p = 0.047) reduction and increment in the enhancement of ANC levels, respectively. The fifth day had WBC (OR = 0.790; 95% CI: 0.675, 0.925; p = 0.003) to be significantly decreasing the likelihood of ANC increment. Conclusions: we were unable to determine any concrete prognostic role of lymphocyte-related measures and ratios. It is plausible that several limitations could have influenced the results obtained, but as far as our analysis is concerned ALC role as a predictive factor for ANC changes remains questionable. MDPI 2022-10-24 /pmc/articles/PMC9695543/ /pubmed/36363465 http://dx.doi.org/10.3390/medicina58111508 Text en © 2022 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Article Halalsheh, Omar M. Al Zu’bi, Yazan O. Al Sharie, Ahmed H. Wafai, Farouk H. Alabdallah, Nadeem AlSeidi, Jumana Hussein, Alia A. Daoud, Majd N. Malkawi, Abubaker A. Alomari, Ahmad O. Alshari, Osama The Prognostic Utility of Lymphocyte-Based Measures and Ratios in Chemotherapy-Induced Febrile Neutropenia Patients following Granulocyte Colony-Stimulating Factor Therapy |
title | The Prognostic Utility of Lymphocyte-Based Measures and Ratios in Chemotherapy-Induced Febrile Neutropenia Patients following Granulocyte Colony-Stimulating Factor Therapy |
title_full | The Prognostic Utility of Lymphocyte-Based Measures and Ratios in Chemotherapy-Induced Febrile Neutropenia Patients following Granulocyte Colony-Stimulating Factor Therapy |
title_fullStr | The Prognostic Utility of Lymphocyte-Based Measures and Ratios in Chemotherapy-Induced Febrile Neutropenia Patients following Granulocyte Colony-Stimulating Factor Therapy |
title_full_unstemmed | The Prognostic Utility of Lymphocyte-Based Measures and Ratios in Chemotherapy-Induced Febrile Neutropenia Patients following Granulocyte Colony-Stimulating Factor Therapy |
title_short | The Prognostic Utility of Lymphocyte-Based Measures and Ratios in Chemotherapy-Induced Febrile Neutropenia Patients following Granulocyte Colony-Stimulating Factor Therapy |
title_sort | prognostic utility of lymphocyte-based measures and ratios in chemotherapy-induced febrile neutropenia patients following granulocyte colony-stimulating factor therapy |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9695543/ https://www.ncbi.nlm.nih.gov/pubmed/36363465 http://dx.doi.org/10.3390/medicina58111508 |
work_keys_str_mv | AT halalshehomarm theprognosticutilityoflymphocytebasedmeasuresandratiosinchemotherapyinducedfebrileneutropeniapatientsfollowinggranulocytecolonystimulatingfactortherapy AT alzubiyazano theprognosticutilityoflymphocytebasedmeasuresandratiosinchemotherapyinducedfebrileneutropeniapatientsfollowinggranulocytecolonystimulatingfactortherapy AT alsharieahmedh theprognosticutilityoflymphocytebasedmeasuresandratiosinchemotherapyinducedfebrileneutropeniapatientsfollowinggranulocytecolonystimulatingfactortherapy AT wafaifaroukh theprognosticutilityoflymphocytebasedmeasuresandratiosinchemotherapyinducedfebrileneutropeniapatientsfollowinggranulocytecolonystimulatingfactortherapy AT alabdallahnadeem theprognosticutilityoflymphocytebasedmeasuresandratiosinchemotherapyinducedfebrileneutropeniapatientsfollowinggranulocytecolonystimulatingfactortherapy AT alseidijumana theprognosticutilityoflymphocytebasedmeasuresandratiosinchemotherapyinducedfebrileneutropeniapatientsfollowinggranulocytecolonystimulatingfactortherapy AT husseinaliaa theprognosticutilityoflymphocytebasedmeasuresandratiosinchemotherapyinducedfebrileneutropeniapatientsfollowinggranulocytecolonystimulatingfactortherapy AT daoudmajdn theprognosticutilityoflymphocytebasedmeasuresandratiosinchemotherapyinducedfebrileneutropeniapatientsfollowinggranulocytecolonystimulatingfactortherapy AT malkawiabubakera theprognosticutilityoflymphocytebasedmeasuresandratiosinchemotherapyinducedfebrileneutropeniapatientsfollowinggranulocytecolonystimulatingfactortherapy AT alomariahmado theprognosticutilityoflymphocytebasedmeasuresandratiosinchemotherapyinducedfebrileneutropeniapatientsfollowinggranulocytecolonystimulatingfactortherapy AT alshariosama theprognosticutilityoflymphocytebasedmeasuresandratiosinchemotherapyinducedfebrileneutropeniapatientsfollowinggranulocytecolonystimulatingfactortherapy AT halalshehomarm prognosticutilityoflymphocytebasedmeasuresandratiosinchemotherapyinducedfebrileneutropeniapatientsfollowinggranulocytecolonystimulatingfactortherapy AT alzubiyazano prognosticutilityoflymphocytebasedmeasuresandratiosinchemotherapyinducedfebrileneutropeniapatientsfollowinggranulocytecolonystimulatingfactortherapy AT alsharieahmedh prognosticutilityoflymphocytebasedmeasuresandratiosinchemotherapyinducedfebrileneutropeniapatientsfollowinggranulocytecolonystimulatingfactortherapy AT wafaifaroukh prognosticutilityoflymphocytebasedmeasuresandratiosinchemotherapyinducedfebrileneutropeniapatientsfollowinggranulocytecolonystimulatingfactortherapy AT alabdallahnadeem prognosticutilityoflymphocytebasedmeasuresandratiosinchemotherapyinducedfebrileneutropeniapatientsfollowinggranulocytecolonystimulatingfactortherapy AT alseidijumana prognosticutilityoflymphocytebasedmeasuresandratiosinchemotherapyinducedfebrileneutropeniapatientsfollowinggranulocytecolonystimulatingfactortherapy AT husseinaliaa prognosticutilityoflymphocytebasedmeasuresandratiosinchemotherapyinducedfebrileneutropeniapatientsfollowinggranulocytecolonystimulatingfactortherapy AT daoudmajdn prognosticutilityoflymphocytebasedmeasuresandratiosinchemotherapyinducedfebrileneutropeniapatientsfollowinggranulocytecolonystimulatingfactortherapy AT malkawiabubakera prognosticutilityoflymphocytebasedmeasuresandratiosinchemotherapyinducedfebrileneutropeniapatientsfollowinggranulocytecolonystimulatingfactortherapy AT alomariahmado prognosticutilityoflymphocytebasedmeasuresandratiosinchemotherapyinducedfebrileneutropeniapatientsfollowinggranulocytecolonystimulatingfactortherapy AT alshariosama prognosticutilityoflymphocytebasedmeasuresandratiosinchemotherapyinducedfebrileneutropeniapatientsfollowinggranulocytecolonystimulatingfactortherapy |